3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
15
Prostatic Neoplasms
13
Neoplasms
4
Breast Neoplasms
4
Vaginal Neoplasms
2
Uterine Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Endometrial Clear Cell Adenocarcinoma
2
Vulvar Neoplasms
1
Stage IA Uterine Sarcoma
1
Radiation Injuries
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Obesity
1
Neurotoxicity Syndromes
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Liver Neoplasms
1
Fatigue
1
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
1
Endometrial Adenocarcinoma
1
Desmoplastic Small Round Cell Tumor
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Breast Carcinoma In Situ
1
Biliary Tract Neoplasms
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
Brachytherapy
×
Clear all
No trials found.